Safety and efficacy of intrathecal baclofen trials for the treatment of hypertonia: a retrospective cohort study

Keyphrases

• Retrospective Cohort Study 100%
• Intrathecal Baclofen 100%
• Hypertonia 100%
• Pediatric Movement Disorders 20%
• Dystonia 20%
• Spasticity 20%
• Insurance Companies 20%
• Modified Ashworth Scale 20%
• Hospitalization 10%
• Lower Extremity 10%
• Effective Treatment 10%
• Clinical Variables 10%
• Complication Rate 10%
• Non-modifiable Risk Factors 10%
• Multidisciplinary Groups 10%
• Procedural Complications 10%
• Bolus 10%
• Upper Extremity 10%
• Longitudinal Cohort 10%
• Retrospective Analysis 10%
• Insurance 10%
• Subspecialists 10%
• Gross Motor Function Classification System (GMFCS) 10%
• High Surgical Risk 10%
• Post-dural Puncture Headache 10%
• Intrathecal Baclofen Therapy 10%
• Secondary Dystonia 10%
• Age at Test 10%
• Baclofen Pump 10%
• Family Decision 10%
• Fragile Populations 10%
• Factor Variables 10%

Medicine and Dentistry

• Retrospective Cohort Study 100%
• Baclofen 100%
• Muscle Hypertonia 100%
• Dystonia 25%
• Stereotypic Movement Disorder 16%
• Spasticity 16%
• Pediatrics 16%
• Upper Limb 8%
• Prematurity 8%
• Gross Motor Function Classification System 8%
• Surgical Risk 8%
• Post-Dural-Puncture Headache 8%
• Clinician 8%